to frontline therapeutics makes the identification of novel drug targets and the development of 38 corresponding inhibitors vital. Post-translational modifications (PTMs) are important modulators of 39 biology and inhibition of protein lipidation has emerged as a promising therapeutic strategy for 40 treatment of parasitic diseases. In this review we summarise the latest insights into protein lipidation 41 in protozoan parasites. We discuss how recent chemical proteomic approaches have delivered the
INTRODUCTION 49
Infections with protozoan parasites of the genera Plasmodium, Leishmania, Toxoplasma, and 50 Trypanosoma are among the most prevalent diseases in developing countries. Transmission of 51
Plasmodia to human hosts through the bites of infected female Anopheles mosquitoes results in the 52 acute febrile illness malaria. In 2015, 95 countries reported ongoing transmissions, resulting in half of 53 the world's population (3.2 billion people) being at risk of malaria. P. falciparum and P. vivax pose the 54 greatest threats with P. falciparum being responsible for most malaria-related deaths and P. vivax 55 being the most dominant malaria parasite outside of sub-Saharan Africa (WHO, 2015 (Hajjaran et al., 2016) , and 72 melarsoprol and pentamidine in the case of HAT (Baker et al., 2013; Graf et al., 2016) . This highlights 73 an urgent need for new validated drug targets and lead compounds. 74
Post-translational modifications (PTMs) are covalent and predominantly enzymatic modifications of 75 proteins that occur during or after protein translation. One such PTM is the attachment of lipids (e.g. 76 myristic or palmitic acid) to protein N-termini or side chains. Lipidation is typically catalysed by an 77 acyl transferase that utilises the coenzyme A activated lipid as a cofactor. In this review we will focus 78 on two protein lipidations: S-acylation, the attachment of a long chain saturated fatty acid (mainly 79 C16:0, palmitate) to a cysteine side chain via a thioester linkage, and N-myristoylation. N-80 Myristoylation is catalysed by an acyl transferase, N-myristoyl transferase (NMT), which attaches 81 myristic acid to the N-terminus of a specific set of protein substrates in lower and higher eukaryotes, 82 thereby forming an amide bond between the 14-carbon saturated fatty acid and an N-terminal 83 glycine (Boutin, 1997 (Fig. 3C) . As has been noted by the studies described above, it is clear that MTCC 281 and ABE identify not only overlapping but also distinct subsets of the palmitome (and therefore also 282 distinct sets of false positives), and there is value to using both methodologies in combination. In 283 addition, by comparing the P. falciparum data from our myristoylation study with the palmitoylation 284 analyses, we identify 10 likely dually acylated proteins in the parasite (Fig. 3D) . The Apicomplexa 285 comparisons are given in Supplementary Table S1 , although it should be noted that exact numbers in 286 these comparisons are dependent on how the analysis is carried out: orthologues frequently do not 287 map one-to-one and mass spectrometry data often cannot distinguish between closely related 288 proteins, which is a widely studied problem in protein inference (Li and Radivojac, 2012 were identified as high confidence NMT substrates (Fig. 7B) . In addition to proteins involved in 365 trafficking, protein phosphorylation, Golgi function and proteasomal degradation, just over half of 366 the hits are completely uncharacterised. Again, there was good overlap with high confidence T. 367 brucei myristoylated orthologues (Fig. 6C) . 368
Based on this study, it is clear that on-target NMT inhibitors selectively reduce YnMyr (1) 369 incorporation into specific proteins, but do not affect tagging of others (GPI anchored, S-acylated). 370 Indeed, we observed this across Plasmodia, Trypanosoma, and Leishmania parasites, as described 371 above. Since YnMyr (1) incorporation can be assessed on-gel, MTCC provides a rapid method to 372 screen for on-target activity of promising NMT inhibitors in these organisms. 373
374

Comparisons across the trypanosomatids 375
The three studies analysing N-myristoylation using MTCC in T. brucei (Fig. 8B aminoacylpyrrolidines -compound 7 , piperidinylindoles -compound 8, 420 thienopyrimidines, and biphenyl derivatives) with good to excellent selectivity over all other NMTs 421 tested (Bell et al., 2012) . The binding mode of all four inhibitor classes was subsequently determined 422 by co-crystallisation with LdNMT and/or L. major NMT (LmNMT) ( Fig. 8B; (Brannigan et al., 2014) . All 423 inhibitors, apart from the aminoacylpyrrolidines, interact via a basic centre with the C-terminal 424 carboxylate of the enzyme. In the case of 7 and 9, the corresponding interaction is mediated by the 425 hydroxyl substituent. Moreover, all compounds show significant interactions with aromatic side 426 chains of Phe90, Tyr217, and Tyr345, and exhibit an additional set of individual interactions. These 427 structural insights were used in a subsequent structure-guided fusion of scaffolds 7 and 8 (Hutton et 428 al., 2014) . The product (Fig. 8B, compound 9 (Rackham et al., 2014) . The corresponding derivatives (Fig. 9A, compound 15) showed a 100-463 fold improved enzyme affinity and a 100-fold decreased lipophilicity while retaining the selectivity 464 over HsNMT with respect to the first benzo[b]thiophene lead compound 13. Apart from its 465 antiparasitic in vitro activity, compound 15 is potent against four parasite strains, including two drug-466 resistant ones, and shows promising activity against liver stage (EC50 = 372 nM) parasites. 467
Scaffold simplification by substituting the bicyclic core with pyridyl (Fig. 5A, compound 16) resulted 468 in the most recently reported oxadiazole containing inhibitor series (Yu et al., 2015) . Remarkably, the 469 scaffold-simplified inhibitors exhibit a similar binding mode in the PvNMT crystal structure as the 470 benzo[b]furane derivatives (Fig. 9A) . The 1,2,4-oxadiazole is sandwiched between Y334 and Y211, 471 while the pyridyl nitrogen of 16 additionally stabilises the enzyme-inhibitor complex via water-472 mediated hydrogen bonds with Y315. Strikingly, the 3-OMe phenyl moiety of compound 16 also 473 overlays well with the quinoline scaffold of compound 5 (Fig. 8A) . Exchanging the trimethylpyrazole 474 with a quinolone moiety finally provided compound 17 (Fig. 9A) with an IC50 of 1.7 nM against PfNMT 475 and good cellular efficacy. The benzo [b] thiophene series was also routinely tested against LdNMT. 476
Remarkably, the affinity spectrum changes significantly if the bicyclic system is truncated to a 477 monocyclic thiophene scaffold (Rackham et al., 2015) . Activity against human and Plasmodium NMTs 478 decreases by almost two orders of magnitude while affinity against LdNMT increases 8-fold. 479
However, since thiophene moieties have been associated with P450 inhibition, a 1,3,4-oxadiazole 480 containing 5-chlorophenyl derivative was obtained as optimum scaffold that shows no macrophage 481 toxicity. However, the compound failed to inhibit axenic L. donovani amastigotes (leishmanial stage), 482 likely due to difficulty accessing the target in this parasite. Therefore, further investigation of the 483 physicochemical properties of this series is essential. 484
Finally, we also reported development of a PvNMT and LmNMT peptidomimetic inhibitor based on 485 an fungal NMT inhibitor (Olaleye et al., 2014) . The structure of the peptide (Fig. 9B, compound 18 ) 486 comprises a Ser-Lys dipeptide, a C-terminal cyclohexyl moiety, and an aliphatic chain at the N-487 terminus. The resulting peptidomimetic is characterised by sub-micromolar potency against both 488 enzymes and a marginal selectivity over HsNMT. Interestingly, 20% of the electron density of the 489 inhibitor-NMT complex structure corresponds to an N-myristoylated inhibitor product and the CoA 490 by-product, providing the first direct structural evidence for a product complex in NMT (Fig. 9B) . This 491 complex is presumably formed in situ in the crystal, favoured by the high inhibitor occupancy in the 492 solid state. The lead compound of the HTS, DDD85646 (Fig. 10A, compound 19 LmNMT as surrogate. Co-crystallography of the two new TbNMT inhibitor classes with LmNMT 531 revealed that they are characterised by a different binding mode than the sulphonamides (Fig. 10B) .
532
The lead compound of the thiazolidine series (Fig. 10A, compound 21) is characterised by good 533 selectivity over HsNMT, micromolar cellular efficacy, and a good LE value that indicates the potential 534 of the series. The benzomorpholinone series (Fig. 10A, compound 22) contains potent antiparasitic 535 compounds with cellular potencies in the nanomolar range that exhibit BBB permeable compounds. 536
However, the selectivity of the series has to be further improved to enable higher dose levels, and 537 thereby maximising the chances of curing stage 2 infections. 538
CONCLUSIONS 540
Protein lipidation is an essential PTM for metabolic and cellular processes in protozoan parasites, and 541 its modulation offers interesting opportunities for therapy. Therefore, an extensive investigation of 542 the substrates of protozoan acyl transferases and the corresponding downstream effects of their 543 inhibition is essential. In this context ABE and MTCC are powerful techniques that can be used to 544 profile, image, and identify previously unknown lipidated proteins in a data-driven manner and 545 without the need for specific antibodies or protein overexpression. ABE-type approaches can be used 546 on any lysate without the need to optimise incorporation of an analogue and without the risk that 547 the analogue will perturb the system. However, ABE is limited to S-acylation and provides no 548 information on the lipid. MTCC approaches, in contrast, are unbiased and wide in scope. Only 549 proteins dynamically modified during the incubation time with the analogue will be tagged and 550 therefore identified -whilst this can be a potential limitation, more importantly it offers the 551 opportunity for profiling dynamic lipidation through pulse-chase approaches. Evidence from analytical tools has accumulated to the point where S-acylation must be considered a 565 major regulatory pathway in all eukaryotes (Resh, 2016) . The enzymes involved in removal of this 566 modification come from the superfamily of serine hydrolases, and selective small molecule inhibitors 567 are available for some of these enzymes. Their inhibition can lead to interesting and unexpected 568 phenotypes, as mentioned above, and further characterisation of their apparently broad substrate 569 scope and complex localisation will be important in validating them as potential drug targets. In 570 contrast, the diverse class of protein S-palmitoyl transferases (PATs), including >20 genes in humans, 571 has yet to yield to small molecule inhibitor discovery, and the chemical tools available for PATs are 572 effectively non-existent. Indeed, the continued use of 2-BP due to its commercial availability is to 573 greatly compound the challenges of the field due to the exceptional promiscuity of this molecule, as 574 noted above. Robust and widely-applicable CRIPSR-Cas gene-knockout approaches will be an 575 important enabling tool to unpick the roles of PATs in parasites and in the host, but the discovery of 576 cell-active inhibitors selective for the class, or for members of the class, would be transformative for 577 the field, and should be pursued as a high priority. 578
In contrast, the scope for NMT as a target in eukaryotic pathogens is very clear, and may be very 579 broad, as recently demonstrated for helminths (Galvin et al., 2014) . The availability of multiple 580 potent inhibitor series and powerful tools to analyse PTMs in living systems greatly enhances the 581 opportunities for drug development against this target. With the exception of T. brucei, which is 582 rapidly killed by NMT inhibition due to its exceptional reliance on myristoylation-dependent 583 trafficking, NMT inhibition has a quite extended mode of action. This is hypothesised to be due to an 584 indirect dependence on protein degradation: myristoylated proteins that were present prior to 585 inhibition will typically need to undergo some degree of degradation in order for inhibition of co-586 translational myristoylation to impact viability. Careful consideration of compound uptake in cells, 587 distribution/pharmacokinetics and pharmacodynamics (the dynamics of target engagement) will be 588 required to realise the potential of NMT inhibitors as antiparasitic agents, and research towards this 589 objective continues in our labs, in collaboration with other research groups. 590
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Engineering and Physical Sciences Research Council (EPSRC, grant EP/F500416/1). 594 595 Figure 1 . Workflow of the acyl biotin exchange (ABE) approach to identify S-acylated proteins. Free thiols in protein lysates are blocked with N-ethyl maleimide followed by selective cleavage of thioesters using hydroxylamine and labelling of the liberated thiols with HPDP-biotin. Next, a typical proteomics workflow that includes affinity enrichment of the biotinylated proteins, proteolytic digest, and analysis of the peptide fragments by mass spectrometry enables the identification of Sacylated proteins. A control sample that still contains the intact thioesters and therefore no biotin tags facilitates the identification of non-specifically enriched proteins. . compounds shown in B) are fed to cells and incorporated into the corresponding proteins. After cell lysis, an affinity tag is attached to the analogue using bioorthogonal CuAAC. Affinity enrichment followed by tryptic digestion and analysis of the peptide fragments by mass spectrometry facilitates the identification of proteins that exhibit this specific PTM. B) Myristic and palmitic acid probes that have been applied in an MTCC approach in protozoan parasites. Table S1 ). Numbers in the Venn diagrams may differ slightly from those reported in the primary literature due to revisions in sequence databases over time, ID mapping issues (e.g. between the two Tg species analysed in B), and, in diagram C, the manner in which the protein inference problem has been handled; most proteomic analyses group proteins when they cannot be distinguished by mass spectrometry, but here each protein was treated independently. YnMyr (1) is incorporated into proteins via both amide (NaOH-insensitive) and ester (NaOH-sensitive) linkages. Proteomics revealed the base-sensitive incorporation to be on GPI anchored proteins. C) Dose-response of YnMyr (1) incorporation upon co-incubation with NMT inhibitor DDD85646 (19). Ingel fluorescence read-out (graph on the right: quantification of fluorescence intensity) following the workflow shown in Fig. 2A and includinga base-treatment step to remove GPI anchor labelling. ., 2015) . B) Superposition of the crystal structures of aminoacylpyrrolidine 7, piperidinylindole 8, and the corresponding hybridization product 9 in complex with LdNMT (PDB code: 4cgl, compound 7, green; 4cgn, compound 8, blue; 4cyo, compound 9, red) and biological activity of 7, 8, and 9 against LdNMT, HsNMT1, and antiparasitic activity against extracellular amastigotes of L. donovani (Hutton et al., 2014) . The piperidinylindole 8 and the hybridization product 9 show an interaction of a basic centre with the C-terminal carboxylate of NMT. Additionally, all compounds show interactions with a set of aromatic amino acids. 
